Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
Key facts
- Phase
- Phase 4
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Trial code
- NCT02803294
- Record updated
- 15 July 2021
- Original description
The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.Read full original descriptionShow less
THE TORCH TRIAL：Transcatheter Aortic Valve Replacement Single Center Registry in Chinese Population
The purpose of this study is to evaluate the safety and effectiveness of transcatheter aortic valve replacement in Chinese population.
Inclusion: Patients with symptomatic aortic stenosis/regurgitation; Subject has been informed of the nature of the study, agrees to its provisions and has provided written informed consent; The subject agrees to comply with specified follow-up evaluations and to return to the investigational site where the procedure was performed; Patients are technical and anatomical eligible for interventions.
Exclusion: A known hypersensitivity or contraindication to any of the following which cannot be adequately pre-medicated: Aspirin Heparin (HIT/HITTS) and bivalirudin Nitinol (titanium or nickel) Ticlopidine and clopidogrel Contrast media; Other medical, social, or psychological conditions that in the opinion of an Investigator precludes the subject from appropriate consent; Subject refuses a blood transfusion; Life expectancy is less than one year.